Home > Products > FGF2 & VEGF > Recombinant Human Anti-FGF2 x Human Anti-VEGF Bispecific Antibody (Fv-IgG)

Recombinant Human Anti-FGF2 x Human Anti-VEGF Bispecific Antibody (Fv-IgG)  (BSDG-H326)

Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-FGF2 IgG with similar domains from an anti-VEGF antibody via short peptide linkers, or vice versa. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Hepatocellular cancer (HCC); Breast cancer; Colon cancer; Lung cancer; Glioma cancer therapy.

Specifications

Targets
FGF2 & VEGF
Type
Appended IgGs
Species Reactivity
Human
Target 1
FGF2
Host Animal 1
Human
Target 2
VEGF
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Hepatocellular cancer (HCC); Breast cancer; Colon cancer; Lung cancer; Glioma cancer

Targets

Target 1
FGF2
Gene ID
UniProt ID
Alternative Names
FGF; Fibroblast growth factor; FGF2; fibroblast growth factor 2; BFGF; FGFB; FGF-2; HBGF-2
Target 2
VEGF
Gene ID
UniProt ID
Alternative Names
VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-FGF2 x Human Anti-VEGF Bispecific Antibody (Fv-IgG) (BSDG-H326). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "FGF2 & VEGF"
See other bsAb targets related to "VEGF"

Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: